drugset

drugset / Trial / NCT00827580

Eniluracil Hand Foot Syndrome

NCT00827580 ↗

Phase 1 Terminated 3 enrolled West Virginia University

NaSingle-groupDouble-blindTreatment

Summary

A pilot study of eniluracil containing ointment for prevention of hand foot syndrome (HRS) following capecitabine (Xeloda).

Timeline

Start: 2009-01
Primary completion: 2009-09
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	eniluracil	Unknown	—	—

Indications